Dealmaking in the COVID-19 Environment
An On-Demand Webinar Presented by BioCentury & PJT Partners
...
ON-DEMAND RECORDING
RECORDED: August 12, 2020
As the COVID-19 crisis continues to impact biopharma, what is the outlook for dealmaking in the industry?
In this webinar, we discuss key findings from a recent BioCentury-PJT survey about the impact of COVID-19 on biopharma transactions. From deal selection and strategies, to timing and due diligence, global biopharma leaders are considering how to adapt their dealmaking to the COVID-19 era. Following the discussion, BioCentury and PJT convene a special panel of biotech CEOs to discuss the survey, and the outlook for biotech transactions.
HOSTED BY
